Walleye Trading LLC Sage Therapeutics, Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $144,375 - $187,941	-8,443 Reduced 52.76%	7,561 $163,000
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $172,240 - $503,661	10,283 Added 179.74%	16,004 $329,000
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $232,558 - $340,628	5,721 New	5,721 $269,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $160,446 - $219,741	-2,271 Reduced 39.59%	3,465 $259,000
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $24,450 - $72,219	935 Added 19.48%	5,736 $165,000
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $306,533 - $415,062	2,185 Added 83.52%	4,801 $674,000
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $412,935 - $478,963	2,616 New	2,616 $479,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.